Government invests £1.7m into Scottish firms to 'transform' UK healthcare

Three Scottish companies will receive funding for health tech research - part of the UK government’s investment in developing technology to make health and social care better.

The first is RoslinCT, based in Edinburgh. It has been given £887k to develop stem cell therapies for clinical use, working with ReproCELL.

The second is Stormid, in Edinburgh and Glasgow, which has been £586k to develop digital services for patients with lung conditions.

Daysix is the third, also in Edinburgh and Glasgow. It has been granted £290k to develop a clinical decision support app with the potential to change the delivery of international trauma care.

The projects have been funded by the UK government as part of its Industrial Strategy Challenge Fund, managed by UK Research and Innovation.

Today (October 4), UK Minister for Scotland, Lord Ian Duncan, is to visit all three of the Scottish projects.

Speaking ahead of his visits Lord Duncan, said: “This UK Government funding is about supporting breakthrough technologies to transform healthcare across the country for both patients and staff.

“Three Scottish companies will receive more than £1.7m to develop cell-based therapeutics, digital self-management services for lung patients and systems to provide real-time decision support in the care of trauma patients.”

UK Business Secretary, Greg Clark, added: “Technology is revolutionising industries across our economy, and new innovations play a key role in advancing our healthcare.

“We are making every opportunity to reach our full potential in finding new discoveries and technologies to diagnose illnesses earlier that could lead to more lives being saved.”

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →